https://mts.intechopen.com/articles/show/title/radium-223-and-actinium-225-emitter-radiopharmaceuticals-in-treatment-of-metastatic-castration-resisIn recent decades, multiple radiopharmaceutical conjugates have been tested and shown to be efficacious in treating metastasized castration-resistant prostate cancer (mCRPC). Several types of research have been published on the therapeutic use of α-…